⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer

Official Title: A Multi-center, Multi-country Prospective Observational Study of Patients Initiating T-DXd in the First or Second Treatment Line for HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer

Study ID: NCT05592483

Conditions

Breast Cancer

Study Description

Brief Summary: This study will collect real-world clinical and patient reported outcomes (PRO) and diary data from eligible patients with documented Human Epidermal Growth Factor Receptor 2 (HER2+) \[globally\] or HER2-low \[North America only\] in routine clinical practice.

Detailed Description: This is a multi-center, observational prospective study that will characterize the demographic and clinical characteristics, treatment patterns, effectiveness, tolerability and its management, and patient experience of Trastuzumab Deruxtecan (T-DXd) in a real-world setting. This study is planned to be conducted in several countries and aims to enroll approximately 750 patients eligible patients with HER2+ unresectable and/or metastatic breast cancer (mBC) who has received a prior anti HER2 based regimen in the metastatic setting or in the neoadjuvant or adjuvant setting and has developed disease recurrence during or within 6 months of completing therapy. Approximately 250 eligible patients with HER2-low unresectable and/or mBC who have received a prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy will be enrolled into the study in North America only. The planned duration of patient recruitment is approximately 18 months for HER2+ and approximately 12 months for HER2 low.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Research Site, Mobile, Alabama, United States

Research Site, Chandler, Arizona, United States

Research Site, Little Rock, Arkansas, United States

Research Site, Los Angeles, California, United States

Research Site, Santa Rosa, California, United States

Research Site, Pensacola, Florida, United States

Research Site, Atlanta, Georgia, United States

Research Site, Evergreen Park, Illinois, United States

Research Site, Glenview, Illinois, United States

Research Site, Park Ridge, Illinois, United States

Research Site, Lexington, Kentucky, United States

Research Site, Louisville, Kentucky, United States

Research Site, Annapolis, Maryland, United States

Research Site, Boston, Massachusetts, United States

Research Site, Southfield, Michigan, United States

Research Site, Saint Paul, Minnesota, United States

Research Site, Kansas City, Missouri, United States

Research Site, Camden, New Jersey, United States

Research Site, Florham Park, New Jersey, United States

Research Site, Jamaica, New York, United States

Research Site, Lake Success, New York, United States

Research Site, Eugene, Oregon, United States

Research Site, York, Pennsylvania, United States

Research Site, Greenville, South Carolina, United States

Research Site, Germantown, Tennessee, United States

Research Site, Knoxville, Tennessee, United States

Research Site, Memphis, Tennessee, United States

Research Site, Nashville, Tennessee, United States

Research Site, Dallas, Texas, United States

Research Site, El Paso, Texas, United States

Research Site, Fort Worth, Texas, United States

Research Site, McAllen, Texas, United States

Research Site, McKinney, Texas, United States

Research Site, San Antonio, Texas, United States

Research Site, Tyler, Texas, United States

Research Site, Portsmouth, Virginia, United States

Research Site, Roanoke, Virginia, United States

Research Site, Everett, Washington, United States

Research Site, Milwaukee, Wisconsin, United States

Research Site, Wien, Nordrhein-Westfalen, Austria

Research Site, Wels, Oberösterreich, Austria

Research Site, Graz, Steiermark, Austria

Research Site, Innsbruck, Tirol, Austria

Research Site, Wien, , Austria

Research Site, Salvador, Bahia, Brazil

Research Site, Brasilia, Distrito Federal, Brazil

Research Site, Cachoeiro de Itapemirim, Espírito Santo, Brazil

Research Site, Belo Horizonte, Minas Gerais, Brazil

Research Site, Curitiba, Paraná, Brazil

Research Site, Porto Alegre, Rio Grande Do Sul, Brazil

Research Site, Itajai, , Brazil

Research Site, Porto Alegre, , Brazil

Research Site, São Paulo, , Brazil

Research Site, São Paulo, , Brazil

Research Site, Calgary, Alberta, Canada

Research Site, Surrey, British Columbia, Canada

Research Site, Vancouver, British Columbia, Canada

Research Site, Kingston, Ontario, Canada

Research Site, Kitchener, Ontario, Canada

Research Site, Montreal, Quebec, Canada

Research Site, Quebec, , Canada

Research Site, Tel Aviv, Tel-Aviv, Israel

Research Site, Jerusalem, Yerushalayim, Israel

Research Site, Be'er Sheva, , Israel

Research Site, Haifa, , Israel

Research Site, Brescia, , Italy

Research Site, Brindisi, , Italy

Research Site, Catania, , Italy

Research Site, Cremona, , Italy

Research Site, Palermo, , Italy

Research Site, Pisa, , Italy

Research Site, Roma, , Italy

Research Site, Roma, , Italy

Research Site, Torino, , Italy

Research Site, Verona, , Italy

Research Site, Coruña, A Coruña, Spain

Research Site, Elche, Alicante, Spain

Research Site, Zaragoza, Aragón, Spain

Research Site, Oviedo, Asturias, Spain

Research Site, Palma de Mallorca, Baleares, Spain

Research Site, L'Hospitalet De Llobregat, Barcelona, Spain

Research Site, Las Palmas de Gran Canaria, Canarias, Spain

Research Site, Sta. Cruz De Tenerife, Canarias, Spain

Research Site, Santander, Cantabria, Spain

Research Site, Madrid, Comunidad De Madrid, Spain

Research Site, Madrid, Comunidad De Madrid, Spain

Research Site, Jerez de la Frontera, Cádiz, Spain

Research Site, Cordoba, Córdoba, Spain

Research Site, Ourense, Galicia, Spain

Research Site, San Sebastián, Guipúzcoa, Spain

Research Site, Logrono, La Rioja, Spain

Research Site, Majadahonda, Madrid, Spain

Research Site, Pamplona, Navarra, Spain

Research Site, Reus, Tarragona, Spain

Research Site, Baracaldo, Vizcaya, Spain

Research Site, Barcelona, , Spain

Research Site, Barcelona, , Spain

Research Site, Barcelona, , Spain

Research Site, Barcelona, , Spain

Research Site, Burgos, , Spain

Research Site, Cáceres, , Spain

Research Site, Lleida, , Spain

Research Site, Madrid, , Spain

Research Site, Murcia, , Spain

Research Site, Málaga, , Spain

Research Site, Segovia, , Spain

Research Site, Sevilla, , Spain

Research Site, Toledo, , Spain

Research Site, Valencia, , Spain

Research Site, Zaragoza, , Spain

Research Site, Basel, , Switzerland

Research Site, Basel, , Switzerland

Research Site, Bern, , Switzerland

Research Site, Liestal, , Switzerland

Research Site, Monthey, , Switzerland

Research Site, Keighley, England, United Kingdom

Research Site, Rickmansworth, England, United Kingdom

Research Site, Londonderry, Northern Ireland, United Kingdom

Research Site, Inverness, Scotland, United Kingdom

Research Site, Taunton, Somerset, United Kingdom

Research Site, Coventry, , United Kingdom

Research Site, Huddersfield, , United Kingdom

Research Site, Leeds, , United Kingdom

Research Site, Manchester, , United Kingdom

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: